Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 288 across all filing types
Latest filing 2022-07-27 Regulatory Filings
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated July 27, 2022, announcing the expansion of DIAGNOS Inc. services in Canada through a partnership with Labtician Ophthalmics. It discusses business development, partnership details, and product information related to AI-based pathology detection systems. There is no financial data, regulatory filing references, or report attachments. The content is a corporate announcement about business expansion and partnership, not a financial report, audit, or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2022-07-27 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated 27 July 2022 announcing the expansion of DIAGNOS's services in Canada through a partnership with Labtician Ophthalmics. It discusses business development, market expansion, and product deployment but contains no financial statements, earnings data, or regulatory filings. There is no indication of an earnings release, annual or interim report, or any other formal financial report. The content is a corporate announcement about business growth and partnership, typical of a general regulatory announcement or news release. It does not fit into categories like earnings release, annual report, or management report. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2022-07-27 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing the launch of a new product (the SD7 Push-to-Talk over Cellular device) by Siyata Mobile and Logic Wireless. It contains no financial data, no regulatory filings, no management discussion, no earnings information, and no shareholder voting results. It is a corporate press release focused on product and business development news. This type of document does not fit into financial report categories like Annual Report, Earnings Release, or Interim Report. It is also not a regulatory filing or a management announcement about board changes. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements and press releases that do not fit other categories.
2022-07-13 English
52-109FV1 - Certification of annual filings - CFO (F).pdf
Regulatory Filings Classification · 95% confidence The document is an attestation by the Chief Financial Officer regarding the annual documents of Diagnos inc. for the fiscal year ended March 31, 2022. It references the examination of the annual notice, annual financial statements, and management report collectively as 'annual documents'. The document is a certification letter attesting to the accuracy and fair presentation of these documents, specifically under Regulation 52-109 for emerging issuers. It does not contain the actual financial statements or detailed financial data but is a formal attestation related to those documents. According to the Certification Rule, such attestations should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. The document length is 3581 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-07-13 English
52-109FV1 - Certification of annual filings - CEO (F).pdf
Regulatory Filings Classification · 95% confidence The document is an attestation by the CEO regarding the annual documents of Diagnos inc. for the fiscal year ended March 31, 2022. It references the annual notice, annual financial statements, and management report collectively as 'annual documents'. The attestation confirms the accuracy and fair presentation of these documents but does not contain the actual financial statements or detailed financial data itself. It is a certification related to annual filings under Regulation 52-109 for an emerging issuer, specifically an attestation of the annual documents rather than the documents themselves. The document length is 3602 characters, which is relatively short and consistent with a certification or attestation letter rather than a full annual report. According to the rules, a certification or attestation letter, even if referencing annual reports, should be classified as a Regulatory Filing (RNS) rather than the Annual Report (10-K) or Audit Report (AR). Therefore, the correct classification is Regulatory Filings (RNS).
2022-07-13 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of annual filings for the financial year ended March 31, 2022. It explicitly states it is a certification related to annual filings, not the filings themselves. The document is short (3224 characters) and primarily an officer certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the actual annual report or financial statements. Therefore, the correct classification is Regulatory Filings (RNS).
2022-07-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.